Research & Literature

Survival after resection of perihilar cholangiocarcinoma-development and external validation of a prognostic nomogram.

Groot Koerkamp B, Wiggers JK, Gonen M, et al.

Annals of oncology : official journal of the European Society for Medical Oncology 2015; (26(9)):1930-1935 doi:10.1093/annonc/mdv279.

Hilar cholangiocarcinoma: expert consensus statement.

Mansour JC, Aloia TA, Crane CH, et al.

HPB : the official journal of the International Hepato Pancreato Biliary Association 2015; (17(8)):691-9 doi:10.1111/hpb.12450.

Evaluating the Clinical Applicability of the European Staging System for Perihilar Cholangiocarcinoma.

Ismael HN, Loyer E, Kaur H, et al.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2016; (20(4)):741-7 doi:10.1007/s11605-016-3075-5.

Actual Long-Term Survival Outcome of 403 Consecutive Patients with Hilar Cholangiocarcinoma.

Kang MJ, Jang JY, Chang J, et al.

World journal of surgery 2016; (40(10)):2451-9 doi:10.1007/s00268-016-3551-9.

MDCT assessment of resectability in hilar cholangiocarcinoma.

Ni Q, Wang H, Zhang Y, et al.

Abdominal radiology (New York) 2017; (42(3)):851-860 doi:10.1007/s00261-016-0943-0.

Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.

Ethun CG, Lopez-Aguiar AG, Anderson DJ, et al.

Annals of surgery 2018; (267(5)):797-805 doi:10.1097/SLA.0000000000002574.

Adjuvant Therapy Is Associated With Improved Survival in Resected Perihilar Cholangiocarcinoma: A Propensity Matched Study.

Nassour I, Mokdad AA, Porembka MR, et al.

Annals of surgical oncology 2018; (25(5)):1193-1201 doi:10.1245/s10434-018-6388-7.

Comparison of the 7th and 8th editions of the American Joint Committee on Cancer Staging Systems for perihilar cholangiocarcinoma.

Ruzzenente A, Bagante F, Ardito F, et al.

Surgery 2018; (164(2)):244-250 doi:10.1016/j.surg.2018.03.012.

Imaging Diagnosis of Intrahepatic and Perihilar Cholangiocarcinoma: Recent Advances and Challenges.

Joo I, Lee JM, Yoon JH

Radiology 2018; (288(1)):7-13 doi:10.1148/radiol.2018171187.

Klatskin tumors and "Klatskin-mimicking lesions": our 22-year experience.

Tsalis K, Parpoudi S, Kyziridis D, et al.

Revista espanola de enfermedades digestivas 2019; (111(2)):121-128 doi:10.17235/reed.2018.5749/2018.

Differentiating IgG4-related sclerosing cholangiopathy from cholangiocarcinoma using CT and MRI: experience from a tertiary referring center.

Swensson J, Tirkes T, Tann M, et al.

Abdominal radiology (New York) 2019; (44(6)):2111-2115 doi:10.1007/s00261-019-01944-1.

Radial margin status should be determined in resected perihilar cholangiocarcinoma.

de Wilde RF, Groot Koerkamp B

Hepatobiliary surgery and nutrition 2019; (8(5)):557-559 doi:10.21037/hbsn.2019.07.19.

Prognostic impact of the Bismuth-Corlette classification: Higher rates of local unresectability in stage IIIb hilar cholangiocarcinoma.

Passeri MJ, Baimas-George MR, Sulzer JK, et al.

Hepatobiliary & pancreatic diseases international : HBPD INT 2020; (19(2)):157-162 doi:10.1016/j.hbpd.2020.02.001.

Prognostic Relevance of the Eighth Edition of TNM Classification for Resected Perihilar Cholangiocarcinoma.

Hau HM, Meyer F, Jahn N, et al.

Journal of clinical medicine 2020; (9(10)) doi:10.3390/jcm9103152.

Selected Patients with Unresectable Perihilar Cholangiocarcinoma (pCCA) Derive Long-Term Benefit from Liver Transplantation.

Azad AI, Rosen CB, Taner T, et al.

Cancers 2020; (12(11)) doi:10.3390/cancers12113157.

Machine-learning radiomics to predict early recurrence in perihilar cholangiocarcinoma after curative resection.

Qin H, Hu X, Zhang J, et al.

Liver international : official journal of the International Association for the Study of the Liver 2021; (41(4)):837-850 doi:10.1111/liv.14763.

Novel Targeted Therapies for Advanced Cholangiocarcinoma.

Rizzo A, Brandi G

Medicina (Kaunas, Lithuania) 2021; (57(3)) doi:10.3390/medicina57030212.

Impact of Combined Vascular Resection and Reconstruction in Patients with Advanced Perihilar Cholangiocarcinoma.

Kuriyama N, Komatsubara H, Nakagawa Y, et al.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract 2021; (25(12)):3108-3118 doi:10.1007/s11605-021-05004-2.

Chemotherapy for Biliary Tract Cancer in 2021.

Sasaki T, Takeda T, Okamoto T, et al.

Journal of clinical medicine 2021; (10(14)) doi:10.3390/jcm10143108.

Single-center experience of liver transplantation for perihilar cholangiocarcinoma.

Ahmed O, Vachharajani N, Chang SH, et al.

HPB : the official journal of the International Hepato Pancreato Biliary Association 2022; (24(4)):461-469 doi:10.1016/j.hpb.2021.08.940.

Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings.

Notohara K

Journal of medical ultrasonics (2001) 2021; (48(4)):581-594 doi:10.1007/s10396-021-01148-5.

Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study.

Bridgewater J, Fletcher P, Palmer DH, et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022; (40(18)):2048-2057 doi:10.1200/JCO.21.02568.

Current Perspectives on the Surgical Management of Perihilar Cholangiocarcinoma.

Hewitt DB, Brown ZJ, Pawlik TM

Cancers 2022; (14(9)) doi:10.3390/cancers14092208.

A New Strategy of Liver Transplantation for Locally Advanced Unresectable Perihilar Cholangiocarcinoma Using Living Grafts With Simultaneous Resection of Recipients' Hepatic Artery and Portal Vein Without Neoadjuvant Radiation: A Case Report.

Miyagi S, Fujio A, Nakagawa K, et al.

Transplantation proceedings 2022; (54(6)):1643-1647 doi:10.1016/j.transproceed.2022.03.054.

Effects of portal vein resection and hepatic artery resection on long-term survival in Klatskin tumor: a meta-analysis.

Song Y, Zhang Y, Zhen Z, Huang Z

World journal of surgical oncology 2022; (20(1)):230 doi:10.1186/s12957-022-02692-1.

The Impact of KRAS Mutational Status on Long-Term Survival following Liver Resection for Hilar Cholangiocarcinoma.

Ardito F, Razionale F, Campisi A, et al.

Cancers 2022; (14(18)) doi:10.3390/cancers14184370.

A novel nomogram for adult primary perihilar cholangiocarcinoma and considerations concerning lymph node dissection.

Zhang Q, Liu Z, Liu S, et al.

Frontiers in surgery 2022; (9()):965401 doi:10.3389/fsurg.2022.965401.

Role of neoadjuvant chemoradiotherapy in liver transplantation for unresectable perihilar cholangiocarcinoma: multicentre, retrospective cohort study.

Hoogwater FJH, Kuipers H, de Meijer VE, et al.

BJS open 2023; (7(2)) doi:10.1093/bjsopen/zrad025.

Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of Guidelines and Recent Advancements.

Padmanaban V, Ruff SM, Pawlik TM

Cancers 2023; (16(1)) doi:10.3390/cancers16010030.

Liver transplantation as an alternative for the treatment of perihilar cholangiocarcinoma: A critical review.

Andraus W, Tustumi F, Santana AC, et al.

Hepatobiliary & pancreatic diseases international : HBPD INT 2024; (23(2)):139-145 doi:10.1016/j.hbpd.2024.01.003.

Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma.

Malik AK, Davidson BR, Manas DM

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2025; (51(2)):108248 doi:10.1016/j.ejso.2024.108248.

Survival outcomes of surgical resection in perihilar cholangiocarcinoma in endemic area of O. Viverrini, Northeast Thailand.

Sarkhampee P, Junrungsee S, Tantraworasin A, et al.

Asian journal of surgery 2024; (47(7)):2991-2998 doi:10.1016/j.asjsur.2024.03.116.

Case report: Isolated immunoglobulin G4-related sclerosing cholangitis misdiagnosed as hilar cholangiocarcinoma.

Li H, Wang R, Wang D, et al.

Frontiers in oncology 2024; (14()):1385214 doi:10.3389/fonc.2024.1385214.

Advanced Cholangiocarcinoma With High Tumor Mutation Burden Achieving Complete Response to Immune Check Point Inhibitor.

Okabe H, Masuda T, Nitta H, et al.

Anticancer research 2024; (44(7)):3199-3203 doi:10.21873/anticanres.17135.

Perihilar Cholangiocarcinoma Originating in Peribiliary Glands: Insights from a Case without Precancerous Lesions.

Shirota Y, Ueda Y, Nakanuma Y, et al.

The American journal of case reports 2024; (25()):e945519 doi:10.12659/AJCR.945519.

Primary neuroendocrine tumor of the perihilar bile duct: A case report.

Salış M, Kandemir M, Gündoğdu E, et al.

Turkish journal of surgery 2024; (40(3)):261-263 doi:10.47717/turkjsurg.2022.4595.

Pathological Complete Response after Pembrolizumab Treatment for Unresectable Perihilar Cholangiocarcinoma with High Microsatellite Instability: A Case Report.

Inokawa Y, Mizuno H, Yamada M, et al.

Surgical case reports 2025; (11(1)) doi:10.70352/scrj.cr.25-0025.

Long-term survival after multidisciplinary treatment including durvalumab for recurrent perihilar cholangiocarcinoma.

Miyata T, Nagayama T, Nishiki H, et al.

Clinical journal of gastroenterology 2026; (19(3)):627-631 doi:10.1007/s12328-026-02301-8.

Differentiating Immunoglobulin G4-Related Sclerosing Cholangitis From Primary Sclerosing Cholangitis: A Comprehensive Systematic Review and Meta-Analysis of Diagnostic Features.

Wang MC, Chong AC, Grave EC, et al.

The American journal of gastroenterology 2026; doi:10.14309/ajg.0000000000004024.